AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SODIUM VALPROATE 200 Mg ;

10 registrations across 1 African market— 10 active

Markets with SODIUM VALPROATE 200 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Leptoprenol 200 mg
Enteric Coated Tablet
🇪🇬EgyptEgyptian Company for Health Care Products and Pharmaceutical Trading ( EGYPHARMA )active
Valaleptine 200mg
Enteric Coated Tablet
🇪🇬EgyptMisr Saudi pharmaceutical Co.active
valponex
Enteric Coated Tablet
🇪🇬EgyptWestern Pharmaceuticals Industriesactive
Depakine®
Oral Solution
🇪🇬EgyptSANOFI scientific officeactive
Depakine®
Oral Solution
🇪🇬EgyptSANOFI scientific officeactive
Valaleptine 200mg
Enteric Coated Tablet
🇪🇬EgyptMisr Saudi pharmaceutical Co.active
Leptoprenol 200 mg
Enteric Coated Tablet
🇪🇬EgyptEgyptian Company for Health Care Products and Pharmaceutical Trading ( EGYPHARMA )active
valponex
Enteric Coated Tablet
🇪🇬EgyptWestern Pharmaceuticals Industriesactive
DEKADEL
Oral Solution
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive
DEKADEL
Oral Solution
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive

SODIUM VALPROATE 200 Mg ; in Africa — Regulatory Overview

SODIUM VALPROATE 200 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.